熊貓綠能(00686.HK)擬發行1.12億美元有擔保優先票據
格隆匯1月15日丨熊貓綠能(00686.HK)公告,交換要約已於2020年1月14日下午四時正(倫敦時間)屆滿。於交換屆滿期限,1.08億美元現有票據(相當於尚未償還現有票據全部本金總額約30.85%)已根據交換要約有效交出以作交換並獲接納。
於交換要約完成時,公司將向於交換要約中有效接納及交換現有票據合資格持有人發行本金額合共1.12億美元交換票據,作為部分交換代價。本公司將申請交換票據於聯交所上市。交換票據獲納入不應視為本公司、附屬公司擔保人或交換票據價值指標。
交換票據預期將於2020年1月21日或前後在聯交所上市。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.